Full Text View
Tabular View
No Study Results Posted
Related Studies
Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient
This study has been completed.
Study NCT00566137   Information provided by North Shore Long Island Jewish Health System
First Received: November 29, 2007   Last Updated: January 22, 2009   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

November 29, 2007
January 22, 2009
February 2006
 
 
Complete list of historical versions of study NCT00566137 on ClinicalTrials.gov Archive Site
 
 
 
Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient
Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient

To determine sleep disturbance, pulmonary function test, 6 minute walk, echocardiogram abnormality, arterial blood gas, ventilation/perfusion scan of the chest in Scleroderma patient with Pulmonary Hypertension.

As above

 
Observational
Cohort, Retrospective
  • Scleroderma
  • Pulmonary Hypertension
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
50
February 2007
 

Inclusion Criteria:

  • Patient must have Scleroderma

Exclusion Criteria:

  • Patients who do not have Scleroderma
Both
18 Years to 75 Years
No
 
 
 
 
NCT00566137
ARUNABH TALWAR MD, NORTH SHORE- LONG ISLAND HEALTH SYSTEM
NS-LIJHS IRB #06-08-018
North Shore Long Island Jewish Health System
 
Principal Investigator: Arunabh Talwar, MD North Shore Long Island Jewish Health System
North Shore Long Island Jewish Health System
November 2007

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.